Any feedback?
Literature summary for 1.1.1.239 extracted from
- Increased expression of type 2 3alpha-hydroxysteroid dehydrogenase/type 5 17beta-hydroxysteroid dehydrogenase (AKR1C3) and its relationship with androgen receptor in prostate carcinoma (2006), Endocr. Relat. Cancer, 13, 169-180.
Organism
| Organism | UniProt | Comment | Textmining |
|---|---|---|---|
| Homo sapiens | - |
- |
- |
Source Tissue
| Source Tissue | Comment | Organism | Textmining |
|---|---|---|---|
| endothelial cell | - |
Homo sapiens | - |
| perineurium | - |
Homo sapiens | - |
| prostate gland | androgen target tissues | Homo sapiens | - |
| prostatic urethra | - |
Homo sapiens | - |
Synonyms
| Synonyms | Comment | Organism |
|---|---|---|
| AKR1C3 | multi-functional enzyme that possesses 3alpha-, 17beta-, 20alpha-hydroxysteroid dehydrogenase, as well as prostaglandine F synthase activities and catalyzes androgen, estrogen, progestin and prostaglandin metabolism. It is a member of the aldo-keto reductase superfamily. | Homo sapiens |
| type 2 3alpha-hxdroxysteroid dehydrogenase/type 5 17beta-hydroxysteroid dehydrogenase | - |
Homo sapiens |
Use of this online version of BRENDA is free under the CC BY 4.0 license. See terms of use for full details.
Release 2023.1 (January 2023)
Legal
Curated at
Member of
